JPL
JPL is a InhA-cofactor-ligand 3FNG inhibitor, and can be used for study of tuberculosis[1].
Product Specifications
CAS Number
952588-18-0
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/jpl.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC=C(C(Cl)=C1)OC2=CC=C(CC3CCCCC3)C=C2O
Molecular Formula
C19H20Cl2O2
Molecular Weight
351.27
References & Citations
[1]da Silva Lima CH, et al. Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors. Int J Mol Sci. 2015;16 (10) :23695-23722. Published 2015 Oct 7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
